--- title: "5-Day Report, Definition | MedTech Terms" description: "Expedited FDA MDR for events requiring remedial action to prevent unreasonable risk of substantial harm. Plain-English Post-Market definition for MedTech teams," lang: en json-ld: | { "@context": "https://schema.org", "@graph": [ { "@type": "DefinedTerm", "@id": "https://medtechterms.com/terms/five-day-report#term", "name": "5-Day Report", "description": "21 CFR 803.53 requires a 5-Day Report when a manufacturer becomes aware that a reportable event necessitates remedial action to prevent unreasonable risk. Filed in addition to standard 30-day MDRs as applicable.", "url": "https://medtechterms.com/terms/five-day-report", "termCode": "five-day-report", "inDefinedTermSet": { "@type": "DefinedTermSet", "name": "MedTech Terms", "url": "https://medtechterms.com/terms" } }, { "@type": "Article", "@id": "https://medtechterms.com/terms/five-day-report#article", "headline": "5-Day Report", "description": "Expedited FDA MDR for events requiring remedial action to prevent unreasonable risk of substantial harm.", "url": "https://medtechterms.com/terms/five-day-report", "mainEntityOfPage": { "@type": "WebPage", "@id": "https://medtechterms.com/terms/five-day-report" }, "about": { "@id": "https://medtechterms.com/terms/five-day-report#term" }, "articleSection": "Post-Market", "inLanguage": "en", "keywords": "5-Day Report, Post-Market, medical device, MedTech", "author": { "@type": "Person", "name": "Christian Espinosa", "jobTitle": "Founder, Blue Goat Cyber", "url": "https://bluegoatcyber.com" }, "publisher": { "@type": "Organization", "name": "MedTech Terms", "url": "https://medtechterms.com" }, "isPartOf": { "@type": "WebSite", "name": "MedTech Terms", "url": "https://medtechterms.com" }, "datePublished": "2026-05-05", "dateModified": "2026-05-05", "citation": [ { "@type": "CreativeWork", "name": "21 CFR 803", "url": "https://www.ecfr.gov/current/title-21/chapter-I/subchapter-H/part-803", "publisher": { "@type": "Organization", "name": "eCFR" } }, { "@type": "CreativeWork", "name": "FDA MAUDE Database", "url": "https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfmaude/search.cfm", "publisher": { "@type": "Organization", "name": "FDA" } }, { "@type": "CreativeWork", "name": "FDA Recalls - Medical Devices", "url": "https://www.fda.gov/medical-devices/medical-device-safety/medical-device-recalls", "publisher": { "@type": "Organization", "name": "FDA" } } ], "mentions": [ { "@type": "DefinedTerm", "@id": "https://medtechterms.com/terms/mdr#term", "name": "EU Medical Device Regulation", "alternateName": "MDR", "url": "https://medtechterms.com/terms/mdr" }, { "@type": "DefinedTerm", "@id": "https://medtechterms.com/terms/fsca#term", "name": "Field Safety Corrective Action", "alternateName": "FSCA", "url": "https://medtechterms.com/terms/fsca" } ] }, { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "Home", "item": "https://medtechterms.com/" }, { "@type": "ListItem", "position": 2, "name": "Terms", "item": "https://medtechterms.com/terms" }, { "@type": "ListItem", "position": 3, "name": "Post-Market", "item": "https://medtechterms.com/terms?cat=Post-Market" }, { "@type": "ListItem", "position": 4, "name": "5-Day Report", "item": "https://medtechterms.com/terms/five-day-report" } ] }, { "@type": "FAQPage", "@id": "https://medtechterms.com/terms/five-day-report#faq", "mainEntity": [ { "@type": "Question", "name": "What is the primary distinction between a 5-Day Report and a 30-Day MDR?", "acceptedAnswer": { "@type": "Answer", "text": "A 5-Day Report is specifically required when a manufacturer identifies a reportable event necessitating immediate remedial action to prevent an unreasonable risk of substantial harm, whereas a 30-Day MDR covers most other reportable adverse events." } }, { "@type": "Question", "name": "Can a 5-Day Report be filed simultaneously with a 30-Day MDR?", "acceptedAnswer": { "@type": "Answer", "text": "Yes, if an event meets the criteria for both, a 5-Day Report must be filed within five days, and a comprehensive 30-Day MDR may follow, or the 5-Day report can serve as the initial submission for the 30-Day MDR if all required information is present." } }, { "@type": "Question", "name": "What constitutes an urgent ", "acceptedAnswer": { "@type": "Answer", "text": "An 'urgent' or 'remedial action' often refers to actions taken to mitigate a severe risk, such as device recall, field safety notice, or immediate design change to prevent further harm, as outlined in FDA guidance." } }, { "@type": "Question", "name": "What happens if a manufacturer misses the 5-day deadline?", "acceptedAnswer": { "@type": "Answer", "text": "Missing the 5-day deadline can result in non-compliance, potentially leading to FDA enforcement actions, including Warning Letters or civil penalties, as timeliness is a critical aspect of post-market surveillance." } } ] } ] } --- [ MedTech Terms The authoritative reference ](/) Browse Learn [Latest](/latest) About 1. [Home](/) 2. / 3. [Terms](/terms) 4. / 5. [Post-Market](/terms?cat=Post-Market) 6. / 7. 5-Day Report [All terms](/terms) Post-Market [Regulated Pathways](/ecosystems/regulated-pathways)[Quality System](/ecosystems/quality-system)[Post-Market & Safety](/ecosystems/post-market-safety)[Global Markets](/ecosystems/global-markets) # 5-Day Report Expedited FDA MDR for events requiring remedial action to prevent unreasonable risk of substantial harm. Reviewed by [Christian Espinosa, Founder, Blue Goat Cyber](/authors/christian-espinosa) Last reviewed May 5, 2026 ## Definition 21 CFR 803.53 requires a 5-Day Report when a manufacturer becomes aware that a reportable event necessitates remedial action to prevent unreasonable risk. Filed in addition to standard 30-day MDRs as applicable. What the regulation says The FDA, under 21 CFR 803.53, mandates a 5-Day Report when a manufacturer determines that a reportable event requires prompt remedial action to prevent an unreasonable risk of substantial harm to the public health. This report supplements the standard 30-day Medical Device Reporting ( [MDR](/terms/mdr-reporting)) requirements outlined in 21 CFR Part 803. Regulators expect manufacturers to have robust processes for identifying events that meet the criteria for expedited reporting. ## What this means in practice Triggers tend to be safety-relevant trends or single severe events; misreading the threshold is a common 483 finding. ## Examples - A manufacturer discovers a critical software bug in an implanted cardiac device that could lead to sudden device failure, prompting immediate communication with users and a software update, requiring a 5-Day Report. - Following several complaints of severe patient injury linked to a specific design flaw in a surgical instrument, the manufacturer initiates a voluntary recall, triggering the need for a 5-Day Report. - A MedTech company becomes aware of a cybersecurity vulnerability in their network-connected infusion pump that allows unauthorized remote access, leading to an immediate patch release and a 5-Day Report. Common pitfalls - • Misinterpreting the "unreasonable risk of substantial harm" threshold is a common compliance pitfall, leading to underreporting. - • Failing to initiate a 5-Day Report concurrently with determining the need for remedial action can result in a late submission. - • Assuming a 30-day MDR is always sufficient without evaluating the need for expedited reporting is a frequent mistake. - • Inadequate documentation of the decision-making process for filing or not filing a 5-Day Report can lead to regulatory scrutiny. - • Not clearly defining "remedial action" within internal procedures can cause confusion and reporting delays. ## Frequently asked questions What is the primary distinction between a 5-Day Report and a 30-Day MDR? A 5-Day Report is specifically required when a manufacturer identifies a reportable event necessitating immediate remedial action to prevent an unreasonable risk of substantial harm, whereas a 30-Day [MDR](/terms/mdr-reporting) covers most other reportable adverse events. Can a 5-Day Report be filed simultaneously with a 30-Day MDR? What constitutes an urgent What happens if a manufacturer misses the 5-day deadline? ## Related terms Grouped by theme ### Editor's picks · Hand-selected related concepts [ Post-Market Field Safety Corrective Action(FSCA) Action taken to reduce a risk of serious deterioration in health associated with a device. ](/terms/fsca)[ Regulatory EU Medical Device Regulation(MDR) Regulation (EU) 2017/745 governing medical devices in the European Union. ](/terms/mdr) ### More in Post-Market · Same category [ Post-Market Annual Report (PMA) Yearly report required for Class III PMA devices summarizing changes, complaints, and post-approval study status. ](/terms/annual-report-pma)[ Post-Market Customer Notification Letter Communication to users notifying them of a safety issue, corrective action, or important product information. ](/terms/customer-notification)[ Post-Market Electronic Medical Device Reporting(eMDR) FDA's mandatory electronic submission system for Medical Device Reports. ](/terms/emdr)[ Post-Market FDA Recall Classifications I, II, III FDA's risk-based grading of recalls based on potential for harm. ](/terms/recall-classifications) Cited by Where this term appears across MedTech Terms. Ecosystems (4) - [Regulated Pathways](/ecosystems/regulated-pathways) - [Quality System](/ecosystems/quality-system) - [Post-Market & Safety](/ecosystems/post-market-safety) - [Global Markets](/ecosystems/global-markets) ## Primary references 3 sources Link health: 3 verified · last checked 2026-06-20 eCFR· 1 FDA· 2 1. [1 21 CFR 803 Verified eCFR · ecfr.gov ](https://www.ecfr.gov/current/title-21/chapter-I/subchapter-H/part-803) 2. [2 FDA MAUDE Database Verified FDA · accessdata.fda.gov ](https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfmaude/search.cfm) 3. [3 FDA Recalls - Medical Devices Verified FDA · fda.gov ](https://www.fda.gov/medical-devices/medical-device-safety/medical-device-recalls) Inline markers like \[1\] jump to the matching reference above. Sponsor note ### Post-market cybersecurity surveillance? We help MedTech teams stand up vulnerability monitoring, coordinated disclosure, and post-market reporting workflows. [Book a 30-minute discovery session](https://go.bluegoatcyber.com/meetings/blue-goat-cyber/discovery-session) - No obligation - Expert-led from minute one - NDA available on request MedTech Terms is a community resource sponsored by [Blue Goat Cyber](https://bluegoatcyber.com). Definitions are independent of any vendor. On this term Category Post-Market Sources 3 Updated 5/5/2026 [Compare with another term](/compare?a=five-day-report) Learn in 60 seconds Card Lesson Quiz Expedited FDA MDR for events requiring remedial action to prevent unreasonable risk of substantial harm. - · Triggers tend to be safety-relevant trends or single severe events; misreading the threshold is a common 483 finding. - · Filed in addition to standard 30-day MDRs as applicable. Remember this Watch out: Misinterpreting the "unreasonable risk of substantial harm" threshold is a common compliance pitfall, leading to underreporting. Related terms - [EU Medical Device Regulation(MDR) ](/terms/mdr) - [Field Safety Corrective Action(FSCA) ](/terms/fsca) You may also need Auto-suggested from Post-Market and shared keywords. - [Trend Reporting (MDR/MIR) ](/terms/trend-reporting) - [Class III Device ](/terms/class-iii) - [Annual Report (PMA) ](/terms/annual-report-pma) - [Electronic Medical Device Reporting(eMDR) ](/terms/emdr) - [Field Action vs Recall ](/terms/field-action-vs-recall) - [Manufacturer Incident Report(MIR) ](/terms/mir) [All Post-Market terms](/terms?cat=Post-Market) From the Blue Goat network Related resources and services on this topic. - [ Code Blue Real medical device cybersecurity incidents and their lessons. ](https://codebluechart.com) MedTech Terms An authoritative, plain-language reference for the regulatory, quality, cybersecurity, and software terms that shape modern medical devices. Browse - [All terms](/terms) - [A–Z index](/a-z) - [Categories](/categories) - [Ecosystems](/ecosystems) - [Learning paths](/paths) - [Compare terms](/compare) - [Quiz](/quiz) Resources - [FDA Medical Devices](https://www.fda.gov/medical-devices) - [EU MDR](https://eur-lex.europa.eu/eli/reg/2017/745/oj) - [IMDRF](https://www.imdrf.org/) - [Methodology](/methodology) - [Changelog](/changelog) - [Editor: Christian Espinosa](/authors/christian-espinosa) - [About this site](/about) © 2026 MedTech Terms. Reference content for educational purposes - not regulatory advice. A community resource sponsored by [Blue Goat Cyber](https://bluegoatcyber.com)